Fact Sheet
View
Donate Now

One by One

the gains are won

ANNUAL REPORT 2024

One by One

the gains are won

ANNUAL REPORT 2024

SCROLL DOWN

Download 2024 Annual Report
Go

One by One

During FY24 The Task Force for Global Health and our partners marked a milestone, celebrating 40 years of impact. During this time, the world saw extraordinary progress: deaths of children under five dropped by 60%; polio cases declined by 99%, nearing eradication; and 50 countries eliminated at least one neglected tropical disease, protecting their communities from horrific diseases that blind, disable and stigmatize. 

Behind those numbers are millions of people, each contributing to this progress. The community worker who goes door to door to deliver treatment and health information. The parent who vaccinates her child. The elected official whose policy ensures that all districts have systems to monitor disease outbreaks. The donor whose investment helps build sustainable health systems. The program manager who coordinates a multi-country initiative with data, systems and supply chains that enable health providers to deliver services when and where needed, contributing to global health security.

One by one, the gains are won.

The Task Force is honored to have contributed to these achievements and many others, using the collaborative approach with which The Task Force was founded in 1984 to protect children from vaccine-preventable diseases. Building upon the success of our early years, the scope of our work has broadened to tackle several other audacious challenges. But the core approach remains the same: a strong sense of purpose grounded in the belief that all people have the right to health; a laser focus on results; and a partnership model that drives everything we do.

This year’s annual report celebrates those who, one by one, are building a world where all people have the opportunity to lead healthy lives free from preventable suffering, disability and death.

A Personal Note

Each year The Task Force for Global Health discovers new opportunities to expand our global reach–bringing together experts, global health specialists and large organizations into dynamic, goal-oriented coalitions that measurably improve and protect lives both at home and abroad.

But how does this happen, particularly in today’s changing global health environment? As this annual report reminds us, it is the sum total of countless individual actions that drive previously unimaginable gains, such as the elimination of dreadful diseases in dozens of countries, or reaching millions of children and nomadic populations in remote areas who previously went without life-saving vaccines. As you read this report, we hope you will enjoy learning more about how this remarkable work unfolds in places around the world, from Burkina Faso, South Sudan and Somalia to India, the United States and more than 130 other countries.

Whether you are a partner, donor or simply a global health enthusiast, please know that your support helps power the tremendous progress of The Task Force and its partners at every turn. Without you, we could not help global health innovators to establish new laboratories, apply modern technology to improve disease outbreak responses, or move transformational research discoveries into the hands of healthcare professionals where they will matter most.

This annual report highlights not only the extraordinary impact that public health professionals have in our world, but also the fragility and interdependence of global health systems. It reminds us that diseases don’t stop at borders and that we all share a biosphere where extremely contagious and debilitating diseases pose continuing challenges to our collective health–challenges that require constantly evolving scientific and policy solutions.

As you read on, we hope you will share our great pride and inspiration in the dedicated and inspiring work of global health actors in some of the remotest places on earth–work that reduces diseases, improves health systems, creates resilient communities and helps shield all of us against infectious diseases and other health threats each day.

With gratitude for your partnership,

Patrick O'Carroll, President & CEO
Kent Alexander, Board Chair
Click on the tiles below for stories about people helping others and, one by one, improving lives around the world. Efforts like these have resulted in extraordinary progress over the last 40 years and pave the way for future gains.
Introduction
One by One
Our Programs
Where We Work
Leadership
Financials
Donors & Partners
Click on the tiles below for stories about people helping others and, one by one, improving lives around the world. Efforts like these have resulted in extraordinary progress over the last 40 years and pave the way for future gains.
One Disease
Detective
One epidemiologist equipping countries to stop outbreaks
Click Here
One Vaccine Advocate
One vaccine advocate sharing her story to help others
Click Here
One Innovator
One innovator advancing technology to detect diseases
Click Here
One Polio Expert
One polio expert protecting children in Somalia
Click Here
One Physician
One physician serving across borders
Click Here
One Ministry of Health Team
One ministry of health team ending preventable blindness
Click Here
One Data Management Scientist
One data management scientist paving the way to end polio in Afghanistan
Click Here
One Pair of Hepatitis Experts
One pair of hepatitis experts positioning Uruguay for success
Click Here

One Voice

Global & Federal Affairs

The Task Force contributes our expertise to advance effective public health policies in the U.S. and globally, through our formal partnerships with the United Nations and World Health Organization (WHO). We advocate for policy and funding decisions and build partnerships with key policymakers. For example:
Click Here

One milestone: 40 years of impact

In 2024, The Task Force for Global Health marked our 40th anniversary, celebrating four decades of impact.

Watch the video below (click the arrow) and read more here to learn the highlights. 

One Disease
Detective
One epidemiologist equipping countries to stop outbreaks
Click Here
One Vaccine Advocate
One vaccine advocate sharing her story to help others
Click Here
One Innovator
One innovator advancing technology to detect diseases
Click Here
One Polio Expert
One polio expert protecting children in Somalia
Click Here
One Physician
One physician serving across borders
Click Here
One Ministry of Health Team
One ministry of health team ending preventable blindness
Click Here
One Data Management Scientist
One data management scientist paving the way to end polio in Afghanistan
Click Here
One Pair of Hepatitis Experts
One pair of hepatitis experts positioning Uruguay for success
Click Here

One Voice

Global & Federal Affairs

The Task Force contributes our expertise to advance effective public health policies in the U.S. and globally, through our formal partnerships with the United Nations and World Health Organization (WHO). We advocate for policy and funding decisions and build partnerships with key policymakers, including in the U.S. Congress.
Read More

One milestone: 40 years of impact

In 2024, The Task Force for Global Health marked our 40th anniversary, celebrating four decades of impact.

Watch the video below (click the arrow) and read more here to learn the highlights. 

Our Programs

The Task Force for Global Health has nearly 20 programs that work with partners in nearly 140 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. Click each program below to learn more.

Eliminate Diseases

Eliminating diseases means reducing the incidence of infections in a specific geographical area, either to zero for some infections or to a point where the public health impact of the disease is no longer evident. This involves comprehensive strategies encompassing prevention, treatment, and healthcare improvements, and it often requires collaboration between countries and organizations.

Ensure Access to Vaccines

Ensuring access to vaccines means making sure everyone has the opportunity to get vaccinated, regardless of their location, income, or other barriers to access. 

Strengthen Health systems

Strengthening health systems is a multifaceted process focused both on improving public health systems (which protect whole communities, like outbreak detection and control) and improving access to high quality, efficient healthcare systems, aiming for better health outcomes for the population. 

Eliminate Diseases

Eliminating diseases means reducing the incidence of infections in a specific geographical area, either to zero for some infections or to a point where the public health impact of the disease is no longer evident. This involves comprehensive strategies encompassing prevention, treatment, and healthcare improvements, and it often requires collaboration between countries and organizations.

Ensure Access to Vaccines

Ensuring access to vaccines means making sure everyone has the opportunity to get vaccinated, regardless of their location, income, or other barriers to access. 

Strengthen Health Systems

Strengthening health systems is a multifaceted process focused both on improving public health systems (which protect whole communities, like outbreak detection and control) and improving access to high quality, efficient healthcare systems, aiming for better health outcomes for the population. 

Where We Work

Hover over the shaded countries on the map below for information about our programs. To sort the map by programs or sectors, click on the filters just above the map.

Leadership Team

FY 24 Financials

Revenue

FY 24 Revenue: $96.9 Million

Excluding Contributions In-Kind*
  • Program support: 86%
  • Indirect cost recovery: 14%
Source of funding for Program Support
  • Government: 56%
  • Corporation: 27%
  • Foundation: 11%
  • Other: 5%

Expenses

Excluding Contributions In-Kind*
  • Access to Vaccines: 41%
  • Neglected Tropical Diseases: 24%
  • Health System Strengthening: 21%
  • Admin & fundraising: 14%
Use of Contributions In-Kind
  • ITI Zithromax: 90%
  • MDP Mectizan®: 10%

Consolidated Financial Report

Consolidated Financial Statement

AR 24 Consolidated Financial Statement
Click Here


*Contributions in Kind are donations of medicine to prevent and treat diseases such as trachoma, lymphatic filariasis and onchocerciasis.

FY 24 Financials

Revenue

FY 24 Revenue: $96.9 Million

Excluding Contributions In-Kind*
  • Program support: 86%
  • Indirect cost recovery: 14%
Source of funding for Program Support
  • Government: 56%
  • Corporation: 27%
  • Foundation: 11%
  • Other: 5%

Expenses

Excluding Contributions In-Kind*
  • Access to Vaccines: 41%
  • Neglected Tropical Diseases: 24%
  • Health System Strengthening: 21%
  • Admin & fundraising: 14%
Use of Contributions In-Kind
  • ITI Zithromax: 90%
  • MDP Mectizan®: 10%

Consolidated Financial Report

Consolidated Financial Statement

AR 24 Consolidated Financial Statement
Click Here


*Contributions in Kind are donations of medicine to prevent and treat diseases such as trachoma, lymphatic filariasis and onchocerciasis.

Donors & Partners

The Task Force for Global Health is grateful for the generosity of our funding partners and donors. The following individuals, foundations, corporations, government agencies, and nongovernmental organizations contributed $500 or more in FY24 (September 2023 to August 2024).

Foundations, corporations, government agencies, and nongovernmental organizations

Abbvie
American Association for the Study of Liver Diseases
ASCENSION
Asian Development Bank
Australian National University
Bayer US LLC
Big Cities Health Coalition
Boehringer Ingelheim
Boston Public Health Commission
Brother’s Brother Foundation
Bryan Allen Events
CDC Foundation
Centers for Disease Control and Prevention
Coalition for Epidemic Preparedness Innovations
COMISCA
Conrad N. Hilton Foundation
Convera
de Beaumont Foundation
Dynavax Technologies
Eagle Medical Services
Eisai Co.
Emory University
Evoke Incisive Health
Federal Home Loan Bank of Atlanta
Gates Foundation
Gilead Sciences
GlaxoSmithKline
Global Health Campus 
Global Institute For Disease Elimination
Health Campaign Effectiveness
Hobson and Lucas Family Foundation
Huffington Family Foundation
Imperial College
Inter American Development Bank
International Network on Health and Hepatitis in Substance Users
Izumi Foundation
John C. Martin Foundation
Johnson & Johnson
Leprosy Research Initiative
Medical Bridges
Medwish International
Merck & Co
Microsoft
Minnesota Department of Health
National Association of Chronic Diseases
National Institute for Occupational Safety & Health
Novartis Foundation
Pan American Health Organization
PDB Foundation
Pfizer Inc.
Pharco Pharmaceuticals Inc.
Resolve to Save Lives
ROCHE Molecular System
Sanofi Espoir Foundation
Sasakawa Health Foundation
Shionogi
Social Science Research Council
SOS International Inc.
The Albert B. Sabin Vaccine Institute
The Global Fund
The London School of Hygiene & Tropical Medicine
Thomas M Harvey Trust
University of Minnesota
University of Nebraska Medical Center
University of Washington, WA
USAID
Vertex
Virion Therapeutics
Washington University
World Health Organization
Zydus Lifesciences

 

 

Individuals

Kent and Diane Alexander
Julie Armstrong
Jakob Arstein
Andrew Becke
James Becker
Dylan Brock
Debby and Tim Coleman
Stephen Collins
Jackson de Campos
Walter M Deriso
Roberta E Dickinson
Elizabeth Ditz
Craig Egan
Karen Ernst
Carol Feinberg
Mary Beth Forrest
B. S. Friedberg
John and Judy Friess
Marc Goodheart
Kimberly Hagen
John B. Hardman
Thomas M. Harvey
Alan Hinman
James Jackson
Stephen Keith
Deborah Kilpatrick
Steve Linowes
Geeta Manek
Quince Marcum
Teri and Roderick McClure
Mark Mckinlay
Charles and Margaret McTier
Abby Milstein
Leighton E Moss
James Niewenhuis
Patrick O’Carroll
Paul A Offit
Walter and Diane Orenstein
Edwina Payne
Diane and Kent Peterson
Jesse Plymale
Dorit Rubinstein
Bushra Sayed-Ganguly
Melissa Schneider
Gregg Sylvestor
Samantha Speede
Edward S Stokan
Jacob Trefethen
Sharon M Tsai
Ari R Weinstein
Deborah L Wexler
Ellen Wild
Erin Wong

Foundations, corporations, government agencies, and nongovernmental organizations

Abbvie
American Association for the Study of Liver Diseases
ASCENSION
Asian Development Bank
Australian National University
Bayer US LLC
Big Cities Health Coalition
Boehringer Ingelheim
Boston Public Health Commission
Brother’s Brother Foundation
Bryan Allen Events
CDC Foundation
Centers for Disease Control and Prevention
Coalition for Epidemic Preparedness Innovations
COMISCA
Conrad N. Hilton Foundation
Convera
de Beaumont Foundation
Dynavax Technologies
Eagle Medical Services
Eisai Co.
Emory University
Evoke Incisive Health
Federal Home Loan Bank of Atlanta
Gates Foundation
Gilead Sciences
GlaxoSmithKline
Global Health Campus 
Global Institute For Disease Elimination

Health Campaign Effectiveness
Hobson and Lucas Family Foundation
Huffington Family Foundation
Imperial College
Inter American Development Bank
International Network on Health and Hepatitis in Substance Users
Izumi Foundation
John C. Martin Foundation
Johnson & Johnson
Leprosy Research Initiative
Medical Bridges
Medwish International
Merck & Co
Microsoft
Minnesota Department of Health
National Association of Chronic Disease Directors
National Institute for Occupational Safety & Health
Novartis Foundation
Pan American Health Organization
PDB Foundation
Pfizer Inc.
Pharco Pharmaceuticals Inc.
Resolve to Save Lives
ROCHE Molecular System

Sanofi Espoir Foundation
Sasakawa Health Foundation
Shionogi
Social Science Research Council
SOS International Inc.
The Albert B. Sabin Vaccine Institute
The Global Fund
The London School of Hygiene & Tropical Medicine
Thomas M Harvey Trust
University of Minnesota
University of Nebraska Medical Center
University of Washington, WA
USAID
Vertex
Virion Therapeutics
Washington University
World Health Organization
Zydus Lifesciences

Individuals

Kent and Diane Alexander
Julie Armstrong
Jakob Arstein
Andrew Becke
James Becker
Dylan Brock
Debby and Tim Coleman
Stephen Collins
Jackson de Campos
Walter M Deriso
Roberta E Dickinson
Elizabeth Ditz
Craig Egan
Karen Ernst
Carol Feinberg
Mary Beth Forrest
B. S. Friedberg
John and Judy Friess
Marc Goodheart
Kimberly Hagen
John B. Hardman
Thomas M. Harvey
Alan Hinman
James Jackson
Stephen Keith
Deborah Kilpatrick
Steve Linowes
Geeta Manek

Quince Marcum
Teri and Roderick McClure
Mark Mckinlay
Charles and Margaret McTier
Abby Milstein
Leighton E Moss
James Niewenhuis
Patrick O’Carroll
Paul A Offit
Walter and Diane Orenstein
Edwina Payne
Diane and Kent Peterson
Jesse Plymale
Dorit Rubinstein
Bushra Sayed-Ganguly
Melissa Schneider
Gregg Sylvestor
Samantha Speede
Edward S Stokan
Jacob Trefethen
Sharon M Tsai
Ari R Weinstein
Deborah L Wexler
Ellen Wild
Erin Wong

This annual report was designed by Priya Palani; written and edited by Sumon Ray, Jessica Wurst, Lynn Heinisch, Emily Pelton and Emily Conron; and produced thanks to project management by Cari Kaiser.

Scroll to Top
Download Print Fact Sheet
Download Widescreen Fact Sheet